ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety of Quetiapine Fumarate Sustained Release (SEROQUEL SR) in the Treatment of Major Depressive Disorders (OPAL)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00326144
Recruitment Status : Completed
First Posted : May 16, 2006
Last Update Posted : March 25, 2009
Sponsor:
Information provided by:
AstraZeneca

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Completed
  Primary Completion Date : No date given
  Actual Study Completion Date : May 2007
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):